8 Results for "

amylase release

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "amylase release" in MCE Product Catalog:

Cat. No.: HY-112835
CAS No.: 96597-16-9
Purity:  99.42%
Synonyms: pNP-G7
Target:  

Amylases Glycosidase

Research Areas:  

Inflammation/Immunology

Ethylidene-4-nitrophenyl-α-D-Maltoheptaoside (EPS; pNP-G7) serves as a substrate for α-amylase. In the presence of an auxiliary enzyme such as α-glucosidase (α-glucosidase), Ethylidene-4-nitrophenyl-α-D-Maltoheptaoside is degraded by amylase (Amylase) to release a chromophore, enabling the measurement of amylase activity. Ethylidene-4-nitrophenyl-α-D-Maltoheptaoside is applicable for the diagnosis of pancreatitis [2].
loading...
    loading...
Cat. No.: HY-P0039
CAS No.: 136207-23-3
Target:  

Bombesin Receptor

Research Areas:  

Cancer

BIM-26226 is a selective gastrin-releasing peptide receptor (GRPR) (IC50 = 6 nM) and bombesin receptor (BN receptor) antagonist. BIM-26226 antagonizes BN- or GRP-stimulated amylase release with IC50 values of 0.3 nM and 0.2 nM, respectively. BIM-26226 is specific for the GRP-preferring BN receptor subtype with no interference with GRP receptor system. BIM-26226 can induce the synthesis of somatostatin receptor but has no significant effect on tumor growth .
loading...
    loading...
Cat. No.: HY-106525
CAS No.: 55077-30-0
Target:  

Cholinesterase (ChE)

Research Areas:  

Inflammation/Immunology

Aclatonium napadisylate is a cholinergic agonist. Aclatonium napadisylate can increase amylase release and Ca 2+ efflux. Aclatonium napadisylate can stimulate pancreatic exocrine secretion and increase motility and peristalsis of the gastrointestinal tract. Aclatonium napadisylate can be used for the research of gastrointestinal disorders .
loading...
    loading...
Cat. No.: HY-P3899A
Target:  

Somatostatin Receptor

Research Areas:  

Metabolic Disease

[Nle8] Somatostatin (1-28) TFA is a derivative of somatosttin (1-28) with norleucine replacing methionine in position 8. [Nle8] Somatostatin (1-28) TFA increases the amylase release.[Nle8] Somatostatin (1-28) TFA increases the cyclic AMP in pancreatic acini .
loading...
    loading...
Cat. No.: HY-116576
CAS No.: 150351-93-2
Research Areas:  

Metabolic Disease

LY219057 is a potent antagonist of cholecystokinin octapeptide (CCK-8), with the ID50 of 287.5 nM .
loading...
    loading...
Cat. No.: HY-P3899
CAS No.: 84768-30-9
Target:  

Somatostatin Receptor

Research Areas:  

Metabolic Disease

[Nle8] Somatostatin (1-28) is a derivative of somatosttin (1-28) with norleucine replacing methionine in position 8. [Nle8] Somatostatin (1-28) increases the amylase release.[Nle8] Somatostatin (1-28) increases the cyclic AMP in pancreatic acini .
loading...
    loading...
Cat. No.: HY-103282
CAS No.: 108437-87-2
Target:  

Bombesin Receptor

Research Areas:  

Others

[D-Phe12]-Bombesin is a derivative of Bombesin (HY-P0195) and an antagonist for bombesin receptor with Ki of 4.7 μM. [D-Phe12]-Bombesin inhibits the Bombesin (HY-P0195)-induced amylase release, with IC50 of 4 μM .
loading...
    loading...
Cat. No.: HY-129516
CAS No.: 131449-37-1
Research Areas:  

Metabolic Disease

A-70874 is a tyrosine-free tetrapeptide analog of cholecystokinin (30-33) (CCK-4). A-70874 is an agonist that stimulates pancreatic amylase release and a partial agonist that stimulates pancreatic phosphoinositide decomposition. A-70874 has an IC50 of 4.9 nM for the guinea pig pancreatic CCK receptor. Cholecystokinin (CCK) receptors are divided into CCK-A (digestive tract) and CCK-B (brain). A-70874 has an affinity of 1.6 μM for the CCK-B/gastrin receptor .
loading...
    loading...